Thomas Pisano - Nu Skin Independent Director

NUS
 Stock
  

USD 43.84  0.88  1.97%   

  Director
Mr. Thomas R. Pisano is an Independent Director of Nu Skin Enterprises, Inc
Age: 75  Director Since 2008  MBA    
801 345-1000  www.nuskin.com
Pisano served as Chief Executive Officer and a director of Overseas Military Sales Corporationrationration, a marketer of motor vehicles, from 2005 until his retirement in 2010. From 1998 to 2004, he served as the Chief Operating Officer and a director of Overseas Military Sales Corporationrationration From 1995 to 1997, he served as Vice President and Head of the International Division for The Topps Company, Inc., a sports publications and confectionery products company. Prior to that, he served in various positions, including Vice President of Global New Business Development, for Avon Products, Inc., a direct seller of personal care products, from 1969 to 1994. He received a B.S. from the Georgia Institute of Technology and an M.B.A. from Dartmouth College.

Nu Skin Management Efficiency

Nu Skin Enterprises has Return on Asset of 9.46 % which means that on every $100 spent on asset, it made $9.46 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 16.3 %, implying that it generated $16.3 on every 100 dollars invested. Nu Skin management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/05/2022, Return on Investment is likely to grow to 27.17. Also, Return on Average Assets is likely to grow to 11.30. Nu Skin Revenue to Assets are relatively stable at the moment as compared to the past year. Nu Skin reported last year Revenue to Assets of 1.41. As of 07/05/2022, Net Current Assets as percentage of Total Assets is likely to grow to 22.13, while Current Assets are likely to drop slightly above 775.9 M.
The company has 503.78 M in debt with debt to equity (D/E) ratio of 0.55, which is OK given its current industry classification. Nu Skin Enterprises has a current ratio of 1.62, which is typical for the industry and considered as normal. Debt can assist Nu Skin until it has trouble settling it off, either with new capital or with free cash flow. So, Nu Skin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nu Skin Enterprises sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nu Skin to invest in growth at high rates of return. When we think about Nu Skin's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

DIRECTOR Since

Martin FranklinNewell Brands
2016
Ian AshkenNewell Brands
2016
Ernesto ZedilloProcter Gamble
2001
Robert PohladPepsico
2015
Amy ChangProcter Gamble
2017
Raymond ViaultNewell Brands
2002
Chad LeatNorwegian Cruise Ord
2015
Rona FairheadPepsico
2014
Ian CookPepsico
2013
Nelson PeltzProcter Gamble
2018
Francis BlakeProcter Gamble
2015
Ros LEsperanceNewell Brands
2016
Alan GrafNike Inc
2014
Kevin ConroyNewell Brands
2011
Scott CookProcter Gamble
2000
Robert SteeleNewell Brands
2018
Elizabeth ComstockNike Inc
2011
David AbramsNorwegian Cruise Ord
2014
Margaret WhitmanProcter Gamble
2011
John ThompsonNike Inc
2019
Robert SeminaraNorwegian Cruise Ord
2014
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. Nu Skin operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 4600 people. Nu Skin Enterprises (NUS) is traded on New York Stock Exchange in USA and employs 4,600 people.

Nu Skin Enterprises Leadership Team

Elected by the shareholders, the Nu Skin's board of directors comprises two types of representatives: Nu Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nu Skin. The board's role is to monitor Nu Skin's management team and ensure that shareholders' interests are well served. Nu Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nevin Andersen, Independent Director
Scott Pond, Director - Investor Relations
Mark Lawrence, Chief Financial Officer, Executive Vice President
D Dorny, Executive Vice President, General Counsel, Secretary
Ritch Wood, CFO, Principal Accounting Officer and VP
Daniel Campbell, Lead Independent Director
Edwina Woodbury, Independent Director
Zhequing Shen, Director
Chayce Clark, Executive Vice President General Counsel
Joseph Chang, Executive Vice President - Product Development, Chief Scientific Officer
Truman Hunt, CEO and President and Director
Laura Nathanson, Independent Director
Steven Lund, Executive Chairman of the Board
Matthew Dorny, VP, General Counsel and Secretary
Emma Battle, Director
Connie Tang, Executive Vice President Chief Global Growth & customer Experience Officer
Thomas Pisano, Independent Director
Neil Offen, Independent Director
Scott Schwerdt, President - Americas Region
Zheqing Shen, Independent Director
Andrew Lipman, Independent Director
James Thomas, Chief Accounting Officer
Ryan Napierski, President, Chief Executive Officer, Director

Nu Skin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nu Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Nu Skin without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nu Skin Enterprises using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Nu Skin Enterprises information on this page should be used as a complementary analysis to other Nu Skin's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Nu Skin Stock analysis

When running Nu Skin Enterprises price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know Nu Skin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.16
Market Capitalization
2.2 B
Quarterly Revenue Growth YOY
-0.11
Return On Assets
0.0916
Return On Equity
0.15
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of Nu Skin that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine Nu Skin value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.